Insulin Resistance in Pulmonary Arterial Hypertension, Is It a Novel Disease Modifier?

BACKGROUND: Recent studies have introduced glucose intolerance and insulin resistance (IR) as novel risk factors in patients with pulmonary arterial hypertension (PAH). OBJECTIVES: We aimed to investigate the prevalence of glucose intolerance and IR in patients with PAH and their correlation with fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderi, Nasim, Boobejame, Pedram, Bakhshandeh, Hooman, Amin, Ahmad, Taghavi, Sepideh, Maleki, Majid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253803/
https://www.ncbi.nlm.nih.gov/pubmed/25478547
http://dx.doi.org/10.5812/cardiovascmed.19710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253803/
https://www.ncbi.nlm.nih.gov/pubmed/25478547
http://dx.doi.org/10.5812/cardiovascmed.19710

Ejemplares similares